BALCHEM CORP (BCPC)
Sector: Materials
2026 Annual Meeting Analysis
BALCHEM CORP · Meeting: June 18, 2026
Directors FOR
2
Directors AGAINST
0
Say on Pay
FOR
Auditor
FOR
Director Elections
Election of Two Class 3 Directors to the Board of Directors
Fischer has served since 2010 with strong relevant operational and M&A experience; BCPC's 3-year return of +38.4% outperforms the company-disclosed peer group median by +50.1 percentage points, well below the 65pp underperformance threshold needed to trigger a vote against, attendance is above 75%, and he holds one outside public board seat (Ingredion), which is within the permitted limit.
Knutson has served since 2018 as Audit Committee Chair with strong financial and food/ag industry credentials; BCPC's peer-relative TSR performance does not trigger a vote against, attendance is above 75%, and he holds no other public board seats.
Both Class 3 director nominees pass all policy screens: no overboarding, no attendance deficiencies, no familial relationships to management, no independence concerns, and BCPC's strong 3-year TSR of +38.4% outperforms the company-disclosed peer group median by +50.1 percentage points — far short of the 65pp underperformance threshold required to trigger a vote against directors where absolute TSR is strongly positive (above +20%).
Say on Pay
✓ FORCEO
Ted Harris
Total Comp
$7,894,874
Prior Support
93.8%%
CEO Ted Harris received total compensation of $7,894,874, which is within a reasonable range for a CEO of a $5.6 billion specialty ingredients company with strong 2025 performance including 8.8% revenue growth and adjusted EBITDA growth of 9.8%. Pay structure is well-designed: approximately 84% of the CEO's compensation is variable and at-risk (well above the 50-60% policy minimum), consisting of a cash incentive plan tied to EBITDA, revenue, and free cash flow targets, plus long-term equity awards split 50% performance shares, 25% stock options, and 25% time-based restricted shares — all with meaningful multi-year performance conditions. The 2023-2025 performance share awards paid out at 155.6% of target based on actual EBITDA growth and relative TSR performance, demonstrating genuine pay-for-performance alignment; BCPC's stock returned +38.4% over three years, outperforming the company-disclosed peer group median by over 50 percentage points, confirming that above-benchmark incentive payouts are justified by shareholder outcomes.
Auditor Ratification
✓ FORAuditor
RSM US LLP
Tenure
21 yrs
Audit Fees
$1,397,207
Non-Audit Fees
$11,000
Non-audit fees (audit-related fees of $5,000 plus tax fees of $6,000 = $11,000) represent less than 1% of audit fees ($1,397,207), well below the 50% threshold that would raise independence concerns. RSM's tenure is approximately 21 years (auditing since 2004), which is below the 25-year threshold that would trigger a vote against. The company also notes that RSM rotates its lead audit engagement partner every five years, and the audit committee has actively pre-approved all services.
Overall Assessment
The 2026 Balchem annual meeting presents a clean ballot with three standard proposals: two director nominees who both pass all policy screens given the company's strong relative stock performance and sound governance practices, an auditor ratification with a very low non-audit fee ratio and tenure below the concern threshold, and a Say-on-Pay vote that merits support given a heavily performance-linked pay structure, strong 2025 business results, and above-peer TSR over three years that justifies above-target incentive payouts. All three proposals receive a FOR determination.
Compensation Peer Group
22 companies disclosed in 2026 proxy filing